Company Filing History:
4 out of 1,036 
3 out of 1,209 
Years Active: 2023-2025
Title: Francesco Borriello: Innovator in Immune Response Modulation
Introduction
Francesco Borriello is a notable inventor based in Jamaica Plain, MA (US). He has made significant contributions to the field of immunology, particularly in the development of compounds that enhance human immune responses. With a total of 4 patents, his work is pivotal in advancing vaccine adjuvants and therapeutic strategies.
Latest Patents
One of Borriello's latest patents focuses on the use of toll-like receptor 2 (TLR-2) agonists for modulating the human immune response. This patent describes TLR2 agonists, including thiophenes, imidazoles, and phenyl-containing compounds, which are designed to enhance immune responses and serve as adjuvants in vaccines. The compounds are useful in treating and preventing various diseases, including proliferative, inflammatory, autoimmune, infectious, and chronic diseases. Another significant patent involves a composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine, aimed at enhancing human immune response and serving as vaccine adjuvants.
Career Highlights
Francesco Borriello has worked with esteemed organizations such as Children's Medical Center Corporation and Dana-Farber Cancer Institute Inc. His career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
Throughout his career, Borriello has collaborated with notable colleagues, including David J. Dowling and Ofer Levy. These partnerships have contributed to the success of his research and the development of his patented technologies.
Conclusion
Francesco Borriello's work in immune response modulation showcases his dedication to improving human health through innovative inventions. His patents represent significant advancements in the field of immunology, with the potential to enhance vaccine efficacy and therapeutic outcomes.